Skip to content

Trial of Vitamin D3 Supplementation in Paediatric Autism

Vitamin D3 for Autism Spectrum Disorder: a Randomized, Double-blind, Placebo-controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02508922
Enrollment
42
Registered
2015-07-27
Start date
2015-09-30
Completion date
2016-07-31
Last updated
2016-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism

Brief summary

To build on a recent case study and open label trial, the investigators want to find out if vitamin D supplementation can influence behavioural and core symptoms of autism.

Detailed description

The investigators will assess behavioural and core symptoms of autism before and after 20 weeks of vitamin D supplementation in a double-blind, placebo-controlled trial.

Interventions

DIETARY_SUPPLEMENTVitamin D3

2,000iu vitamin D drops will be taken daily for 20 weeks

DIETARY_SUPPLEMENTPlacebo

Matching placebo drops will be taken daily for 20 weeks

Sponsors

The National Children's Hospital, Tallaght
CollaboratorOTHER
University of Dublin, Trinity College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Positive autism diagnostic observation schedule * Stable medication regimen * Tolerate phlebotomy

Exclusion criteria

* Unstable or very severe autism * Epilepsy * Renal/liver/gastrointestinal disease

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in stereotypic behaviour from the aberrant behaviour checklistDay 1 and day 140A subscale derived from the validated aberrant behaviour checklist

Secondary

MeasureTime frameDescription
Change from baseline in serum calcium levels, corrected for albuminDay 1 and day 140Total serum calcium levels indicating calcium balance.
Change from baseline in aberrant behaviour checklistDay 1 and day 140A validated scale for use in autism
Change from baseline in cytokinesDay 1 and day 140Serum will be analysed for specific cytokines
Change from baseline in autoimmune markersDay 1 and day 140Serum will be analysed for specific autoimmune markers
Change from baseline in serum 25-hydroxyvitamin D levelsDay 1 and day 140Total vitamin D levels
Change from baseline in repetitive behavior Scale - RevisedDay 1 and day 140A validated scale for use in autism
Change from baseline in Social Responsiveness ScaleDay 1 and day 140A validated scale for use in autism
Change from baseline in Developmental Disabilities-Children's Global Assessment ScaleDay 1 and day 140A clinical global impression of autism
Change from baseline in Vitamin D and Sun QuestionnaireDay 1 and day 140A scale assessing behaviour related to vitamin D
Change from baseline in behaviour Assessment System for Children - Second EditionDay 1 and day 140A validated scale for use in autism

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026